Effect of arsenite, maternal age, and embryonic sex on spina bifida, exencephaly, and resorption rates in the splotch mouse

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 4, 2003, Pages 231-239

  Martin, Lisa J ^a   Machado, Antonio F ^a,b   Loza, M Angelica ^a   Mao, Gloria E ^a   Lee, Grace S ^a   Hovland Jr , David N ^a,c   Cantor, Rita M ^d   Collins, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c AMGEN INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX3; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; EXENCEPHALY; GENOTYPE; HETEROZYGOSITY; LETHALITY; MATERNAL AGE; MOLECULAR INTERACTION; MOUSE; MOUSE STRAIN; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; SEX RATIO; SPINA BIFIDA;

ABNORMALITIES, DRUG-INDUCED; AGE FACTORS; ANIMALS; ARSENITES; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETAL RESORPTION; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEURAL TUBE DEFECTS; PAIRED BOX TRANSCRIPTION FACTORS; PREGNANCY; SEX FACTORS; SODIUM COMPOUNDS; SPINAL DYSRAPHISM; TRANSCRIPTION FACTORS;

MURINAE;

EID: 0141960458     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10006     Document Type: Article

References (90)

1. Aschengrau A, Zierler S, Cohen A. 1989. Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health 44:283-290.
2. Auerbach R. 1954. Analysis of the developmental effects of a lethal mutation in the house mouse. J Exp Zool 127:305-329.
3. Baldwin CT, Hoth CF, Macina RA, Milunsky A. 1995. Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature. Am J Med Genet 58:115-122.
4. Beechey CV, Searle SA. 1986. Mutations at the Sp locus. Mouse News Lett 75:28.
5. Bishop J, Huether CA, Torfs C, et al. 1997. Epidemiologic study of Down syndrome in a racially diverse California population, 1989-1991. Am J Epidemiol 145:134-147.
6. Bolliger CT, van Zijl P, Louw JA. 1992. Multiple organ failure with the adult respiratory distress syndrome in homicidal arsenic poisoning. Respiration 59:57-61.
7. Borzsonyi M, Bereczky A, Rudnai P, et al. 1992. Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary. Arch Toxicol 66:77-78.
8. Center for Disease Control. 1994. Down syndrome prevalence at birth - United States, 1983-1990. MMWR Morb Mortal Wkly Rep 43:617-622
9. Conway SJ, Bundy J, Chen J, et al. 2000. Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the splotch (Sp(2H)) Pax3 mouse mutant. Cardiovasc Res 47:314-328.
10. Conway SJ, Henderson DJ, Kirby ML, et al. 1997. Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse. Cardiovasc Res 36:163-173.
11. Copp AJ, Brook FA, Estibeiro JP, et al. 1990. The embryonic development of mammalian neural tube defects. Prog Neurobiol 35:363-403.
12. Cunningham FG, MacDonald PC, Gant NR, et al. 1997. Pregnancy at the extremes of reproductive life. In: Williams obstetrics. Stamford, CT: Appleton and Lange. p. 569-578.
13. DeSesso JM. 2001. Teratogen update: inorganic arsenic. Teratology 64:170-173.
14. DeSesso JM, Jacobson CF, Scialli AR, et al. 1998. An assessment of the developmental toxicity of inorganic arsenic. Reprod Toxicol 12:385-433.
15. Dickie M. 1964. New splotch alleles in the mouse. J Hered 55:97-101.
16. Edwards J. 1958. Congenital malformations of the central nervous system in Scotland. Br J Prev Soc Med 12:115-130.
17. Elwood M, Little J. 1992a. Maternal age and reproductive history. In: Elwood M, Little J, Elwood H, editors. Epidemiology and control of neural tube defects. Oxford, England: Oxford University Press. p. 391-414.
18. Elwood M, Little J. 1992b. Distribution by sex. In: Elwood M, Little J, Elwood H, editors. Epidemiology and control of neural tube defects. Oxford, England: Oxford University Press. p. 306-323.
19. Elwood M, Little J, Elwood H. 1992. Conclusions. In: Elwood M, Little J, Elwood H, editors. Epidemiology and control of neural tube defects. Oxford, England: Oxford University Press. p. 757-777.
20. Epstein DJ, Vekemans M, Gros P. 1991. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67:767-774.
21. Epstein DJ, Vogan KJ, Trasler DG, Gros P. 1993. A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc Natl Acad Sci USA 90:532-536.
22. Fine EL, Horal M, Chang TI, et al. 1999. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes 48:2454-2462.
23. Fleming A, Copp AJ. 2000. A genetic risk factor for mouse neural tube defects: defining the embryonic basis. Hum Mol Genet 9:575-581.
24. Folmer V, Soares JC, Rocha JB. 2002. Oxidative stress in mice is dependent on the free glucose content of the diet. Int J Biochem Cell Biol 34: 1279-1285.
25. Franz T. 1990. Defective ensheathment of motoric nerves in the Splotch mutant mouse. Acta Anat (Basel) 138:246-253.
26. Franz T. 1992. Neural tube defects without neural crest defects in splotch mice. Teratology 46:599-604.
27. Fraser FC. 1976. The multifactorial/threshold concept-uses and misuses. Teratology 14:267-280.
28. Fraser FC. 1996. Liability, thresholds, malformations, and syndromes. Am J Med Genet 66:75-76.
29. Goulding M, Chalepakis G, Deutsch U, et al. 1991. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 10:1135-1147.
30. Goulding M, Sterrer S, Fleming J, et al. 1993. Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics 17:355-363.
31. Gruss P, Walther C. 1992. Pax in development. Cell 69:719-722.
32. Hall JL, Harris MJ, Juriloff DM. 1997. Effect of multifactorial genetic liability to exencephaly on the teratogenic effect of valproic acid in mice. Teratology 55:306-313.
33. Hanlon DP, Ferm VH. 1977. Placental permeability of arsenate ion during early embryogenesis in the hamster. Experientia 33:1221-1222.
34. Hollier LM, Leveno KJ, Kelly MA, et al. 2000. Maternal age and malformations in singleton births. Obstet Gynecol 96:701-706.
35. Hosmer DW, Lemeshow S. 1989. Applied logistic regression. New York: Wiley.
36. Hoth CF, Milunsky A, Lipsky N, et al. 1993. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet 52:455-462.
37. Hovland DN Jr, Cantor RM, Lee GS, et al. 2000. Identification of a murine locus conveying susceptibility to cadmium-induced forelimb malformations. Genomics 63:193-201.
38. Hovland DN Jr, Machado AF, Scott WJ Jr, Collins MD. 1999. Differential sensitivity of the SWV and C57BL/6 mouse strains to the teratogenic action of single administrations of cadmium given throughout the period of anterior neuropore closure. Teratology 60:13-21.
39. Hughes MF. 2002. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 133:1-16.
40. Ingalls TH, Pugh TF, MacMahon B. 1954. Incidence of anencephalus, spina bifida, and hydrocephalus related to birth rank and maternal age. Br J Prev Soc Med 8:17-23.
41. Ishibashi M, Akazawa S, Sakamaki H, et al. 1997. Oxygen-induced embryopathy and the significance of glutathione-dependent antioxidant system in the rat embryo during early organogenesis. Free Radic Biol Med 22:447-454.
42. Juriloff DM, Harris MJ. 2000. Mouse models for neural tube closure defects. Hum Mol Genet 9:993-1000.
43. Kambe F, Nomura Y, Okamoto T, Seo H. 1996. Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells. Mol Endocrinol 10:801-812.
44. Kitchin KT. 2001. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172:249-261.
45. Kunieda T, Xian M, Kobayashi E, et al. 1992. Sexing of mouse preimplantation embryos by detection of Y chromosome-specific sequences using polymerase chain reaction. Biol Reprod 46:692-697
46. Lang D, Chen F, Milewski R, et al. 2000. Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. J Clin Invest 106:963-971.
47. Larson MA, Kimura K, Kubisch HM, Roberts RM. 2001. Sexual dimorphism among bovine embryos in their ability to make the transition to expanded blastocyst and in the expression of the signaling molecule IFN-tau. Proc Natl Acad Sci USA 98:9677-9682.
48. Leunda-Casi A, Genicot G, Donnay I, et al. 2002. Increased cell death in mouse blastocysts exposed in high D-glucose in vitro: implications of an oxidative stress and alterations in glucose metabolism. Diabetologia 45:571-579.
49. Li J, Liu KC, Jin F, et al. 1999. Transgenic rescue of congenital heart disease and spina bifida in Splotch mice. Development 126:2495-2503.
50. Lindgren A, Danielsson BR, Dencker L, Vahter M. 1984. Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacol Toxicol (Copenh) 54:311-320.
51. Lloyd OL, Lloyd MM, Holland Y. 1984. An unusual sex ratio of births in an industrial town with mortality problems. Br J Obstet Gynaecol 91:901-907.
52. Lugo G, Cassady G, Palmisano P. 1969. Acute maternal arsenic intoxication with neonatal death. Am J Dis Child 117:328-330.
53. Lyster WR. 1977. Arsenic and sex ratio in man. Med J Aust 2:442.
54. MacDonald I, MacLennon H. 1960. A consideration of the treatment of elderly primigravidae. J Obstet Gynecol Br Emp 67:443-450.
55. Machado AF, Hovland DN Jr, Pilafas S, Collins MD. 1999. Teratogenic response to arsenite during neurulation: relative sensitivities of C57BL/6J and SWV/Fnn mice and impact of the splotch allele. Toxicol Sci 51:98-107.
56. Machado AF, Martin LJ, Collins MD. 2001a. Pax3 and the splotch mutations: structure, function, and relationship to teratogenesis, including gene-chemical interactions. Curr Pharm Des 7:751-785.
57. Machado AF, Zimmerman EF, Hovland DN Jr, et al. 2001b. Diabetic embryopathy in C57BL/6J mice. Altered fetal sex ratio and impact of the splotch allele. Diabetes 50:1193-1199.
58. Mansfield PK. 1986. Pregnancy for older women. New York, NY: Praeger Publishers.
59. Miki A, Fujimoto E, Ohsaki T, Mizoguti H. 1988. Effects of oxygen concentration on embryonic development in rats: a light and electron microscopic study using whole-embryo culture techniques. Anat Embryol (Berl) 178:337-343.
60. Milunsky A. 1998. Genetic counseling: preconception and as a prelude to prenatal diagnosis. In: Milunsky A, editor. Genetic disorders and the fetus. Baltimore, MD: The Johns Hopkins University Press. p. 1-32.
61. Moase CE, Trasler DG. 1987. Retinoic acid-induced selective mortality of splotch-delayed mouse neural tube defect mutants. Teratology 36:335-343.
62. Moase CE, Trasler DG. 1989. Spinal ganglia reduction in the splotch-delayed mouse neural tube defect mutant. Teratology 40:67-75.
63. Moase CE, Trasler DG. 1990. Delayed neural crest cell emigration from Sp and Spd mouse neural tube explants. Teratology 42:171-182.
64. Morriss GM, New DA. 1979. Effect of oxygen concentration on morphogenesis of cranial neural folds and neural crest in cultured rat embryos. J Embryol Exp Morphol 54:17-35.
65. Mottet N, Ferm V. 1983. The congenital teratogenicity and perinatal toxicity of metals. In: Clarkson T, Nordberg G, Sager PR, editors. Reproduction and developmental toxicity of metals. New York, NY: Plenum Press. p. 93-125.
66. Naguib KK, Al-Awadi SA, Moussa MA, et al. 1999. Trisomy 18 in Kuwait. Int J Epidemiol 28:711-716.
67. Record R. 1961. Anencephalus in Scotland. Br J Prev Soc Med 15:93-105.
68. Robinson WP, Lorda-Sanchez I, Malcolm S, et al. 1993. Increased parental ages and uniparental disomy 15: a paternal age effect? Eur J Hum Genet 1:280-286.
69. Romero-Maldonado S, Quezada-Salazar CA, Lopez Barrera MD, Arroyo Cabrales LM. 2002. [Effect of risk on the child of an older mother (case-control study)]. Ginecol Obstet Mex 70:295-302.
70. Russell WL, Gower JS. 1950. Offspring from transplanted ovaries of fetal mice homozygous for a lethal gene (Sp) that kills before birth. Genetics 35:133.
71. Russell W. 1947. Splotch, a new mutation in the house mouse, Mus musculus. Genetics 32:102.
72. Sauer MV. 1996. Pregnancy wastage and reproductive aging: the oocyte donation model. Curr Opin Obstet Gynecol 8:226-229.
73. Schroeder HA, Mitchener M. 1971. Toxic effects of trace elements on the reproduction of mice and rats. Arch Environ Health 23:102-106.
74. Seller MJ. 1995. Sex, neural tube defects, and multisite closure of the human neural tube. Am J Med Genet 58:332-336.
75. Shalat SL, Walker DB, Finnell RH. 1996. Role of arsenic as a reproductive toxin with particular attention to neural tube defects. J Toxicol Environ Health 48:253-272.
76. Silver LM. 1995. Mouse genetics. New York, NY: Oxford University Press. p. 73.
77. Smith GH, Lloyd OL, Hubbard FH. 1986. Soil arsenic in Armadale, Scotland. Arch Environ Health 41:120-122.
78. Sohal RS. 2002. Role of oxidative stress and protein oxidation in the aging process(1,2). Free Radic Biol Med 33:37-44.
79. Tell G, Scaloni A, Pellizzari L, et al. 1998. Redox potential controls the structure and DNA binding activity of the paired domain. J Biol Chem 273:25062-25072.
80. Tell G, Zecca A, Pellizzari L, et al. 2000. An 'environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation. Nucleic Acids Res 28:1099-1105.
81. vom Saal FS, Finch CE, Nelson JF. 1994. Natural history and mechanisms of aging in humans, laboratory rodents, and other selected vertebrates. In: Knobil E, Neill J, editors. The physiology of reproduction. New York, NY: Raven Press. p. 1213-1314.
82. Waardenburg PJ. 1951. A new syndrome combining developmental anomalies of the eyelids, eyebrows, and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Genet 3:195-253.
83. Willhite CC, Ferm VH. 1984. Prenatal and developmental toxicology of arsenicals. Adv Exp Med Biol 177:205-228.
84. Wilson JG. 1973. Environment and birth defects. New York: Academic Press.
85. Wise LD, Beck SL, Beltrame D, et al. 1997. Terminology of developmental abnormalities in common laboratory mammals (version 1). Teratology 55:249-292.
86. Wlodarczyk BJ, Bennett GD, Calvin JA, Finnell RH. 1996. Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression. Reprod Toxicol 10:447-454.
87. Yaegashi N, Senoo M, Uehara S, et al. 1998. Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases. J Hum Genet 43:85-90.
88. Zierler S, Theodore M, Cohen A, Rothman KJ. 1988. Chemical quality of maternal drinking water and congenital heart disease. Int J Epidemiol 17:589-594.
89. Zlotogora J. 1997. Dominance and homozygosity. Am J Med Genet 68:412-416.
90. Zlotogora J, Lerer I, Bar-David S, et al. 1995. Homozygosity for Waardenburg syndrome. Am J Hum Genet 56:1173-1178.